Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00433

Submission Number:
00433
Commenter:
Kuttenkuler
State:
Missouri
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
I am an independent pharmacy owner in a town of 17,000. Pharmacies everywhere are being crushed by the abusive power of CVS/Caremark that operates without checks and balances. Just look at how Caremark makes money on every aspect of the drug supply chain. They are industry middlemen profiting from the manufacturers and the dispensers to the plan payers and patient. They are driving up drug prices, promoting the use of certain drugs over others, forcing medical providers to remain silent and costing patients and taxpayers tens of millions of dollars every year. The CVS/Caremark merger with Aetna would create a giant entity with conflicts of interest such as PBM mandates that force plan participants to use PBM-owned pharmacies and PBM-owned specialty pharmacies, or brand name drugs from "preferred" manufacturers.